Frederick W Gluck - Net Worth and Insider Trading
Frederick W Gluck Net Worth
The estimated net worth of Frederick W Gluck is at least $5 Million dollars as of 2024-05-13. Frederick W Gluck is the Director of Amgen Inc and owns about 15,748 shares of Amgen Inc (AMGN) stock worth over $5 Million. Frederick W Gluck is also the Director of CytomX Therapeutics Inc and owns about 296,954 shares of CytomX Therapeutics Inc (CTMX) stock worth over $587,969. Details can be seen in Frederick W Gluck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frederick W Gluck has not made any transactions after 2018-03-26 and currently still holds the listed stock(s).
Transaction Summary of Frederick W Gluck
Frederick W Gluck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frederick W Gluck owns 3 companies in total, including CytomX Therapeutics Inc (CTMX) , Amgen Inc (AMGN) , and HCA Healthcare Inc (HCA) .
Click here to see the complete history of Frederick W Gluck’s form 4 insider trades.
Insider Ownership Summary of Frederick W Gluck
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2018-06-13 | director |
| AMGN | Amgen Inc | 2010-09-08 | director |
| HCA | HCA Healthcare Inc | 2003-07-24 | director |
Frederick W Gluck Latest Holdings Summary
Frederick W Gluck currently owns a total of 2 stocks. Among these stocks, Frederick W Gluck owns 15,748 shares of Amgen Inc (AMGN) as of September 8, 2010, with a value of $5 Million and a weighting of 89.26%. Frederick W Gluck also owns 296,954 shares of CytomX Therapeutics Inc (CTMX) as of March 26, 2018, with a value of $587,969 and a weighting of 10.74%.
Latest Holdings of Frederick W Gluck
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMGN | Amgen Inc | 2010-09-08 | 15,748 | 310.15 | 4,884,242 |
| CTMX | CytomX Therapeutics Inc | 2018-03-26 | 296,954 | 1.98 | 587,969 |
Holding Weightings of Frederick W Gluck
Frederick W Gluck Form 4 Trading Tracker
According to the SEC Form 4 filings, Frederick W Gluck has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 800 shares on September 8, 2010, which brought Frederick W Gluck around $41,888.
According to the SEC Form 4 filings, Frederick W Gluck has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the sale of 5,000 shares on March 26, 2018, which brought Frederick W Gluck around $159,650.
Insider Trading History of Frederick W Gluck
- 1
Frederick W Gluck Trading Performance
GuruFocus tracks the stock performance after each of Frederick W Gluck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frederick W Gluck is -1.38%. GuruFocus also compares Frederick W Gluck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frederick W Gluck within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frederick W Gluck's insider trading performs compared to the benchmark.
Performance of Frederick W Gluck
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.15 | | | | | |
| Relative Return to S&P 500(%) | -5.65 | | | | | |
Frederick W Gluck Ownership Network
Frederick W Gluck Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Frederick W Gluck is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Frederick W Gluck made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Frederick W Gluck Mailing Address
Above is the net worth, insider trading, and ownership report for Frederick W Gluck. You might contact Frederick W Gluck via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
